Personal information
Biography
Barry Campbell started his scientific career in gut endocrine physiology at UCNW Bangor, receiving a BSc with Honours in Zoology with Marine Zoology in 1988, and a PhD in 'Gut endocrine physiology' from University of Liverpool (UoL) in 1991. Following an MRC-funded post-doctoral research position, he held a Wellcome Trust-funded lecturership in intestinal physiology, before being appointed to a full-time academic post in Medicine at Liverpool where his research led to specific understanding of the causes and consequences of altered intestinal mucosal glycosylation that occurs in intestinal inflammation and cancer. He now leads one of the key international research groups investigating bacteria-host intestinal epithelium interactions, particularly Crohn’s disease- and colorectal cancer-mucosa associated Escherichia coli. This includes laboratory studies on epithelial and immune cell responses in 2D cell-line and 3D organoid cultures, and in ex vivo tissue, and translational medicine projects examining effects of antibiotics, environment modulating agents and dietary components. He was awarded a Personal Chair within the University of Liverpool’s Institute of Translational Medicine in 2013. From 2014-2022, he was the ‘Scientists in Gastroenterology’ lead for the British Society of Gastroenterology , supporting education, research and the annual meeting Translational Science Masterclass symposia. The research group is now part of the Department of Infection Biology & Microbiomes, and the Liverpool Microbiome Innovation Centre. He is a member of the UK Gut Microbiota for Health Expert Panel.